Piperacillin-tazobactam versus imipenem-cilastatin for treatment of intra-abdominal infections.

In order to compare the clinical and microbiological efficacies and safety of piperacillin plus tazobactam with those of imipenem plus cilastatin, 134 patients with intra-abdominal infections (73 patients with appendicitis) participated in an open randomized comparative multicenter trial. A total of...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Brismar, B, Malmborg, A S, Tunevall, G, Wretlind, B, Bergman, L, Mentzing, L O, Nyström, P O, Kihlström, E, Bäckstrand, B, Skau, T
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1992
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC245542/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1336347/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.36.12.2766
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!